Intas Group API development and manufacturing offers Accord a vital back integration into raw materials that offers the company customized solutions and high quality active ingredients.
The API unit was established in 2008 with an oncology block which is currently under expansion and will reach a capacity of 24 million tonne per year. Since January 2012, a non-oncology section built on ~ 50.000 sqm will became fully functional.
The API manufacturing facilities are fully compliant with EU, FDA and other authorities and have a number of EU and US DMFs and CEP products.
Research and Development is an integral part of the API unit and its dedicated scientists support both new product development as well as process optimisation.